This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Anti-Cancer, Subject name: Pharmacology
[{'content': 'Which of the following is an anti - VEGF drug? \nSelect and explain. \nA. Adalimumab, B. Bevacizumab, C. Cetuximab, D. Daclizumab', 'role': 'user'}, {'content': "Answer: B \nExplanation: Ans. is 'b' i.e., Bevacizumab Monoclonal AntibodyTargetIndicationTrastuzumabher-2/neuBreast cancerTositumomabCD 20B-cell NHLRituximabCD 20B-cell NHLlbritumomabCD 20B-cell NHLDaclizumabIL-2R (CD-25)ImmunosuppressantBasiliximabIL-2R (CD-25)I mmunosuppressantAbciximabGpII/IIIaAntiplateletPalivizumabFusion proteinRSVInfliximabTNF aRA,Crohn's diseaseEtanerceptTNF aRA (rheumatoid arthritis)OfatumumabCD 20SLEBelimumabBLySSLEEpratuzumabCD 22SLEOcrelizumabCD 20SLEAdalimumabTNF aRAAlefaceptLFA-3Plaque psoriasisAlemtuzumabCD 52B cell CLLBevacizumabVEGFColorectal carcinomaCetuximabEGFRColorectal carcinomaGemtuzumabCD 33AMLEfalizumabCD 1 la chain of LFAPsoriasisOmalizumabIgEBronchial asthmaNatalizumabIntegrin-a4Multiple sclerosisDonesumabRANK ligandOsteoporosisTocilizumabIL-6RSLEPanitumumabEGFRColorectal carcinomaRanibizomabVEGFNeovascular macular degenerationNimotuzumabEGFRSquamous cell carcinoma, gliomaEculizumabC5 complement componentParoxysomal nocturnal hemoglobinuria", 'role': 'assistant'}]